Nrx Pharmaceuticals Inc (NRXP)

$1.85 +0.01 (0.54%)
Market Cap 60.56M
Revenue (ttm) 0.00
Net Income (ttm) -25.13M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE 14.61
Profit Margin 0.00%
Debt to Equity Ratio -0.39
Volume 807,900
Avg Vol 1,085,460
Day's Range N/A - N/A
Shares Out 31.87M
Stochastic %K 25%
Beta 1.97
Analysts Strong Sell
Price Target $38.00

Company Profile

NRx Pharmaceuticals, Inc., a clinical-stage bio-pharmaceutical company, develops novel therapeutics for the treatment of central nervous system disorders comprising suicidal depression, post-traumatic stress disorder, and chronic pain. Its lead drug candidates include NRX-101, an oral, fixed dosed combination of D-cycloserine and lurasidone for suicidal treatment-resistant bipolar depression in patients with sub-acute suicidal ideation and behavior in phase 2 trial; and NRX-100, a preservative-f...

Industry: Biotechnology
Sector: Healthcare
Phone: 484 254 6134
Address:
1201 Orange Street, Suite 600, Wilmington, United States
Outcomes
Outcomes Mar. 21 at 3:49 PM
$IBRX $NRXP
0 · Reply
fuctonfauci
fuctonfauci Mar. 20 at 6:33 PM
$NRXP Another Friday, another week — lots promised, little to nothing achieved. Curious what story he’ll tell next Monday ...
0 · Reply
dontfeedthebashers
dontfeedthebashers Mar. 20 at 1:19 PM
$NRXP
0 · Reply
jonny80s
jonny80s Mar. 20 at 1:05 PM
$NRXP expectations: Javitt will continue collecting paychecks and licensing fees for himself and his family and shareholders will continue to get squeezed. NRXP has funding for a few more months and our 1099 management has done nothing but collect at shareholder’s expense. And if funding does get lined up it will again be at the shareholder’s expense. Waiting.
0 · Reply
StevenL85
StevenL85 Mar. 19 at 5:05 PM
$NRXP what are your expectations? Not sure if we will have any significant news?
1 · Reply
Rolo2024
Rolo2024 Mar. 19 at 4:16 PM
$NRXP When is the next news coming out? Earnings on March 24th? Will there be any updates to the business?
2 · Reply
SoloBueno
SoloBueno Mar. 19 at 2:16 PM
$NRXP If the past is any indication of the future, you can expect him and his social media arm DavidBG to come up with something along these lines: "Complimentary virtual eye exam ( 1200 value) to any person that dines at his restaurant and refers 5 patients to his Florida clinic - this limited offer is only available to his honest investors, their friends, and family members."
0 · Reply
Outcomes
Outcomes Mar. 19 at 11:11 AM
$NRXP .....'In addition to reviewing the Company's financial results for the fiscal year ended December 31, 2025, the Company will provide an update on the significant progress achieved across its drug development programs and the HOPE Therapeutics clinical network, milestones that bring the Company closer to its founding mission of preventing suicide and transforming the treatment of depression and PTSD to improve the lives of patients and bring hope to life.' https://ir.nrxpharma.com/news-releases/news-release-details/nrx-pharmaceuticals-inc-nasdaq-nrxp-report-full-year-2025
2 · Reply
FounderV
FounderV Mar. 19 at 5:59 AM
$NRXP At any time...
1 · Reply
WolfOf_MyStreet
WolfOf_MyStreet Mar. 18 at 7:53 PM
$NRXP gap filled, now we continue higher.
0 · Reply
Latest News on NRXP
NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) to Report Full Year 2025 Financial Results and Provide a Corporate Update on March 24, 2026

Mar 19, 2026, 7:00 AM EDT - 2 days ago

NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) to Report Full Year 2025 Financial Results and Provide a Corporate Update on March 24, 2026

NRx Pharmaceuticals (Nasdaq:NRXP) Announces FDA Bioequivalence Determination by Office of Generic Drugs for NRx's Preservative-Free Ketamine Application

Mar 17, 2026, 7:00 AM EDT - 4 days ago

NRx Pharmaceuticals (Nasdaq:NRXP) Announces FDA Bioequivalence Determination by Office of Generic Drugs for NRx's Preservative-Free Ketamine Application

NRx Pharmaceuticals (Nasdaq:NRXP) Confirms Path to New Drug Application with Real World Data and Broader Proposed Indication for NRX-100 (ketamine) Following Type C FDA Meeting

Mar 16, 2026, 7:00 AM EDT - 5 days ago

NRx Pharmaceuticals (Nasdaq:NRXP) Confirms Path to New Drug Application with Real World Data and Broader Proposed Indication for NRX-100 (ketamine) Following Type C FDA Meeting

HOPE Therapeutics, an NRx Subsidiary (Nasdaq:NRXP) Announces opening of Palm Beach, FL Clinic offering One Day treatment for Depression and PTSD

Mar 9, 2026, 7:00 AM EDT - 12 days ago

HOPE Therapeutics, an NRx Subsidiary (Nasdaq:NRXP) Announces opening of Palm Beach, FL Clinic offering One Day treatment for Depression and PTSD

NRx Pharmaceuticals (Nasdaq: NRXP) Appoints Prof. Joshua Brown MD, PhD, as Chief Medical Innovation Officer

Mar 2, 2026, 7:00 AM EST - 19 days ago

NRx Pharmaceuticals (Nasdaq: NRXP) Appoints Prof. Joshua Brown MD, PhD, as Chief Medical Innovation Officer

NRx Pharmaceuticals (Nasdaq:NRXP) Announces Path to New Drug Application with Real World Data and Broader Proposed Indication for NRX-100 (ketamine) Following Type C FDA Meeting

Feb 17, 2026, 7:00 AM EST - 4 weeks ago

NRx Pharmaceuticals (Nasdaq:NRXP) Announces Path to New Drug Application with Real World Data and Broader Proposed Indication for NRX-100 (ketamine) Following Type C FDA Meeting

NRx Pharmaceuticals (Nasdaq:NRXP) Announces 2025 Annual Meeting Date and Record Date

Jan 16, 2026, 7:03 AM EST - 2 months ago

NRx Pharmaceuticals (Nasdaq:NRXP) Announces 2025 Annual Meeting Date and Record Date

NRx Pharmaceuticals (Nasdaq:NRXP) Announces 70,000 Patient Data on Real World Use of Ketamine for Treatment of Suicidal Depression to be Submitted to the FDA in Support of NRX-100 Approval

Jan 14, 2026, 7:03 AM EST - 2 months ago

NRx Pharmaceuticals (Nasdaq:NRXP) Announces 70,000 Patient Data on Real World Use of Ketamine for Treatment of Suicidal Depression to be Submitted to the FDA in Support of NRX-100 Approval

NRx Pharmaceuticals (Nasdaq:NRXP) and neurocare Group AG Announce Joint Offering of Neuroplastic Therapy Targeting Depression, PTSD, and other mental health afflictions

Jan 5, 2026, 6:57 AM EST - 2 months ago

NRx Pharmaceuticals (Nasdaq:NRXP) and neurocare Group AG Announce Joint Offering of Neuroplastic Therapy Targeting Depression, PTSD, and other mental health afflictions

NRx Pharmaceuticals (Nasdaq:NRXP) announces elimination of all balance sheet debt following equity conversion

Dec 18, 2025, 7:05 AM EST - 3 months ago

NRx Pharmaceuticals (Nasdaq:NRXP) announces elimination of all balance sheet debt following equity conversion

NRx Pharmaceuticals to discuss new NRX-101 pipeline indication for augmentation of Transcranial Magnetic Stimulation

Dec 3, 2025, 7:00 AM EST - 3 months ago

NRx Pharmaceuticals to discuss new NRX-101 pipeline indication for augmentation of Transcranial Magnetic Stimulation

NRx Pharmaceuticals, Inc. (NRXP) Discusses Regulatory Update and Development Pipeline Expansion for Preservative-Free Ketamine Formulation Transcript

Dec 2, 2025, 11:23 AM EST - 3 months ago

NRx Pharmaceuticals, Inc. (NRXP) Discusses Regulatory Update and Development Pipeline Expansion for Preservative-Free Ketamine Formulation Transcript

NRx Pharmaceuticals Announces US Food and Drug Administration (FDA) Receipt of ANDA for KETAFREE™, a Preservative-Free IV Ketamine

Dec 2, 2025, 8:30 AM EST - 3 months ago

NRx Pharmaceuticals Announces US Food and Drug Administration (FDA) Receipt of ANDA for KETAFREE™, a Preservative-Free IV Ketamine

NRx Pharmaceuticals (NASDAQ: NRXP) and HOPE Therapeutics to Host Corporate Update Call

Dec 2, 2025, 7:30 AM EST - 3 months ago

NRx Pharmaceuticals (NASDAQ: NRXP) and HOPE Therapeutics to Host Corporate Update Call

NRx Pharmaceuticals (NASDAQ:NRXP) and HOPE Therapeutics to Present at NobleCon21 - Noble Capital Markets' Twenty First Annual Emerging Growth Equity Conference

Dec 1, 2025, 8:03 AM EST - 3 months ago

NRx Pharmaceuticals (NASDAQ:NRXP) and HOPE Therapeutics to Present at NobleCon21 - Noble Capital Markets' Twenty First Annual Emerging Growth Equity Conference

NRx Pharmaceuticals, Inc. (NRXP) Q3 2025 Earnings Call Transcript

Nov 17, 2025, 11:57 AM EST - 4 months ago

NRx Pharmaceuticals, Inc. (NRXP) Q3 2025 Earnings Call Transcript

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Reports Third Quarter 2025 Financial Results and Provides Corporate Update

Nov 17, 2025, 8:03 AM EST - 4 months ago

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Reports Third Quarter 2025 Financial Results and Provides Corporate Update

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) to Report Third Quarter 2025 Financial Results on November 17, 2025

Nov 12, 2025, 8:31 AM EST - 4 months ago

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) to Report Third Quarter 2025 Financial Results on November 17, 2025

HOPE Therapeutics, Inc., an NRx Pharmaceuticals Subsidiary, Announces First-in-Florida Initiation of One Day (ONE-D) Depression Treatment in Partnership with Ampa Health

Nov 10, 2025, 8:03 AM EST - 4 months ago

HOPE Therapeutics, Inc., an NRx Pharmaceuticals Subsidiary, Announces First-in-Florida Initiation of One Day (ONE-D) Depression Treatment in Partnership with Ampa Health

HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announce Inclusion of Cohen & Associates, LLC of Sarasota, FL into the HOPE Network and Appointment of Dr. Rebecca Cohen as HOPE Medical Director

Oct 20, 2025, 8:03 AM EDT - 5 months ago

HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announce Inclusion of Cohen & Associates, LLC of Sarasota, FL into the HOPE Network and Appointment of Dr. Rebecca Cohen as HOPE Medical Director

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) to Present at Noble Capital Markets October 2025 Emerging Growth Virtual Equity Conference

Oct 6, 2025, 8:03 AM EDT - 5 months ago

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) to Present at Noble Capital Markets October 2025 Emerging Growth Virtual Equity Conference

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Re-Files Abbreviated New Drug Application (ANDA) for KETAFREE™, Preservative-Free IV Ketamine

Sep 29, 2025, 8:03 AM EDT - 6 months ago

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Re-Files Abbreviated New Drug Application (ANDA) for KETAFREE™, Preservative-Free IV Ketamine

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Receives Notification of US Food and Drug Administration Approval of Suitability Petition for NRx's Proposed Strength of Preservative-Free Ketamine

Sep 24, 2025, 8:03 AM EDT - 6 months ago

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Receives Notification of US Food and Drug Administration Approval of Suitability Petition for NRx's Proposed Strength of Preservative-Free Ketamine

HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Complete the Acquisition of Dura Medical; Initial Acquisition in Network of Interventional Psychiatry Clinics

Sep 8, 2025, 8:17 AM EDT - 6 months ago

HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Complete the Acquisition of Dura Medical; Initial Acquisition in Network of Interventional Psychiatry Clinics

NRx Pharmaceuticals (NASDAQ:NRXP) to Participate in a Fireside Chat at H.C. Wainwright's 27th Annual Global Investment Conference on Monday, September 8th

Sep 3, 2025, 8:03 AM EDT - 7 months ago

NRx Pharmaceuticals (NASDAQ:NRXP) to Participate in a Fireside Chat at H.C. Wainwright's 27th Annual Global Investment Conference on Monday, September 8th

UPDATE -- NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Selected to Present at the 2025 Global Passion Project with Matthew Rockefeller, Sponsored by Rockefeller Global Family Office

Sep 2, 2025, 1:19 PM EDT - 7 months ago

UPDATE -- NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Selected to Present at the 2025 Global Passion Project with Matthew Rockefeller, Sponsored by Rockefeller Global Family Office

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Selected to Present at the 2025 Global Passion Project with Matthew Rockefeller and Rockefeller Capital

Sep 2, 2025, 8:41 AM EDT - 7 months ago

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Selected to Present at the 2025 Global Passion Project with Matthew Rockefeller and Rockefeller Capital

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announces Expanded Access Policy for NRX-100 (preservative-free ketamine)

Aug 27, 2025, 8:03 AM EDT - 7 months ago

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announces Expanded Access Policy for NRX-100 (preservative-free ketamine)

NRx Pharmaceuticals, Inc. (NRXP) Q2 2025 Earnings Call Transcript

Aug 20, 2025, 12:23 PM EDT - 7 months ago

NRx Pharmaceuticals, Inc. (NRXP) Q2 2025 Earnings Call Transcript

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Reports Second Quarter 2025 Financial Results and Provides Corporate Update

Aug 18, 2025, 8:10 AM EDT - 7 months ago

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Reports Second Quarter 2025 Financial Results and Provides Corporate Update

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Reschedules Second Quarter 2025 Financial Results Release to August 19, 2025

Aug 13, 2025, 6:06 PM EDT - 7 months ago

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Reschedules Second Quarter 2025 Financial Results Release to August 19, 2025

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) to Report Second Quarter 2025 Financial Results on August 14, 2025

Aug 11, 2025, 4:05 PM EDT - 7 months ago

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) to Report Second Quarter 2025 Financial Results on August 14, 2025

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Granted FDA Fast Track Designation for NRX-100 for Suicidal Ideation in Patients with Depression, including Bipolar Depression

Aug 11, 2025, 8:03 AM EDT - 7 months ago

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Granted FDA Fast Track Designation for NRX-100 for Suicidal Ideation in Patients with Depression, including Bipolar Depression

HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announce Receipt of Final Clearance to Proceed to Closing of Dura Medical Acquisition from Florida's Agency for Health Care Administration (AHCA)

Aug 8, 2025, 8:03 AM EDT - 8 months ago

HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announce Receipt of Final Clearance to Proceed to Closing of Dura Medical Acquisition from Florida's Agency for Health Care Administration (AHCA)

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announces Filing of a Citizen Petition with the US Food and Drug Administration Seeking Removal of Benzethonium Chloride from Ketamine Products

Aug 4, 2025, 8:03 AM EDT - 8 months ago

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announces Filing of a Citizen Petition with the US Food and Drug Administration Seeking Removal of Benzethonium Chloride from Ketamine Products

NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) to Join Fireside Chat at BTIG Virtual Biotech Conference July 29 - 30, 2025

Jul 29, 2025, 8:03 AM EDT - 8 months ago

NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) to Join Fireside Chat at BTIG Virtual Biotech Conference July 29 - 30, 2025

HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announce Agreement to Acquire Interest in Cohen and Associates, LLC for HOPE's Network of Interventional Psychiatry Clinics

Jun 26, 2025, 8:03 AM EDT - 9 months ago

HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announce Agreement to Acquire Interest in Cohen and Associates, LLC for HOPE's Network of Interventional Psychiatry Clinics

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announces Filing of Commissioner's National Priority Voucher Application for Intravenous Ketamine (NRX-100)

Jun 23, 2025, 8:03 AM EDT - 9 months ago

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announces Filing of Commissioner's National Priority Voucher Application for Intravenous Ketamine (NRX-100)

NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) and HOPE Therapeutics, Inc. Announce Strategic Investor Relations Partnership with astr partners

Jun 16, 2025, 8:03 AM EDT - 9 months ago

NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) and HOPE Therapeutics, Inc. Announce Strategic Investor Relations Partnership with astr partners

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) and HOPE Therapeutics, Inc. to Present at H.C. Wainwright 6th Annual Neuro Perspectives Hybrid Conference

Jun 12, 2025, 8:03 AM EDT - 10 months ago

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) and HOPE Therapeutics, Inc. to Present at H.C. Wainwright 6th Annual Neuro Perspectives Hybrid Conference

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Files Abbreviated New Drug Application (ANDA) for Preservative-Free IV Ketamine

Jun 5, 2025, 8:03 AM EDT - 10 months ago

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Files Abbreviated New Drug Application (ANDA) for Preservative-Free IV Ketamine

NRx Pharmaceuticals, Inc. (NRXP) Q1 2025 Earnings Call Transcript

May 16, 2025, 8:46 PM EDT - 11 months ago

NRx Pharmaceuticals, Inc. (NRXP) Q1 2025 Earnings Call Transcript

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Reports First Quarter 2025 Financial Results and Provides Corporate Update

May 15, 2025, 4:03 PM EDT - 11 months ago

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Reports First Quarter 2025 Financial Results and Provides Corporate Update

HOPE Therapeutics, Inc. a subsidiary of NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announces Signing of Term Sheet for $7.8 Million Debt Financing to Fuel HOPE Clinic Acquisitions

May 15, 2025, 10:15 AM EDT - 11 months ago

HOPE Therapeutics, Inc. a subsidiary of NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announces Signing of Term Sheet for $7.8 Million Debt Financing to Fuel HOPE Clinic Acquisitions

HOPE Therapeutics, Inc. and NRx Pharmaceuticals (NASDAQ:NRXP) Announce Signing of Definitive Agreement to Purchase Kadima Neuropsychiatry Institute; Foundational Acquisition for the HOPE Network of Interventional Psychiatry Clinics

May 13, 2025, 8:03 AM EDT - 11 months ago

HOPE Therapeutics, Inc. and NRx Pharmaceuticals (NASDAQ:NRXP) Announce Signing of Definitive Agreement to Purchase Kadima Neuropsychiatry Institute; Foundational Acquisition for the HOPE Network of Interventional Psychiatry Clinics

NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) to Report First Quarter 2025 Financial Results on May 15, 2025

May 12, 2025, 8:03 AM EDT - 11 months ago

NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) to Report First Quarter 2025 Financial Results on May 15, 2025

HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) to Host Investor Event at Mar-A-Lago Club on May 8, 2025

May 6, 2025, 8:03 AM EDT - 11 months ago

HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) to Host Investor Event at Mar-A-Lago Club on May 8, 2025

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Files Patent Application for NRX-100, its Proprietary, Preservative Free Formulation of IV Ketamine

May 5, 2025, 8:03 AM EDT - 11 months ago

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Files Patent Application for NRX-100, its Proprietary, Preservative Free Formulation of IV Ketamine

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announces FDA Award of Filing Fee Waiver for Upcoming NRX-100 (preservative free ketamine) New Drug Application to Treat Patients with Suicidal Depression

Apr 30, 2025, 8:46 AM EDT - 11 months ago

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announces FDA Award of Filing Fee Waiver for Upcoming NRX-100 (preservative free ketamine) New Drug Application to Treat Patients with Suicidal Depression

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) and HOPE Therapeutics™, Inc.to Participate in an H.C. Wainwright @ Home Fireside Discussion on Tuesday, April 22, 2025

Apr 21, 2025, 8:01 AM EDT - 11 months ago

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) and HOPE Therapeutics™, Inc.to Participate in an H.C. Wainwright @ Home Fireside Discussion on Tuesday, April 22, 2025

Outcomes
Outcomes Mar. 21 at 3:49 PM
$IBRX $NRXP
0 · Reply
fuctonfauci
fuctonfauci Mar. 20 at 6:33 PM
$NRXP Another Friday, another week — lots promised, little to nothing achieved. Curious what story he’ll tell next Monday ...
0 · Reply
dontfeedthebashers
dontfeedthebashers Mar. 20 at 1:19 PM
$NRXP
0 · Reply
jonny80s
jonny80s Mar. 20 at 1:05 PM
$NRXP expectations: Javitt will continue collecting paychecks and licensing fees for himself and his family and shareholders will continue to get squeezed. NRXP has funding for a few more months and our 1099 management has done nothing but collect at shareholder’s expense. And if funding does get lined up it will again be at the shareholder’s expense. Waiting.
0 · Reply
StevenL85
StevenL85 Mar. 19 at 5:05 PM
$NRXP what are your expectations? Not sure if we will have any significant news?
1 · Reply
Rolo2024
Rolo2024 Mar. 19 at 4:16 PM
$NRXP When is the next news coming out? Earnings on March 24th? Will there be any updates to the business?
2 · Reply
SoloBueno
SoloBueno Mar. 19 at 2:16 PM
$NRXP If the past is any indication of the future, you can expect him and his social media arm DavidBG to come up with something along these lines: "Complimentary virtual eye exam ( 1200 value) to any person that dines at his restaurant and refers 5 patients to his Florida clinic - this limited offer is only available to his honest investors, their friends, and family members."
0 · Reply
Outcomes
Outcomes Mar. 19 at 11:11 AM
$NRXP .....'In addition to reviewing the Company's financial results for the fiscal year ended December 31, 2025, the Company will provide an update on the significant progress achieved across its drug development programs and the HOPE Therapeutics clinical network, milestones that bring the Company closer to its founding mission of preventing suicide and transforming the treatment of depression and PTSD to improve the lives of patients and bring hope to life.' https://ir.nrxpharma.com/news-releases/news-release-details/nrx-pharmaceuticals-inc-nasdaq-nrxp-report-full-year-2025
2 · Reply
FounderV
FounderV Mar. 19 at 5:59 AM
$NRXP At any time...
1 · Reply
WolfOf_MyStreet
WolfOf_MyStreet Mar. 18 at 7:53 PM
$NRXP gap filled, now we continue higher.
0 · Reply
fuctonfauci
fuctonfauci Mar. 18 at 6:03 PM
$NRXP news after news already seems to be fully priced in. I’m curious to hear what the ophthalmologist, pilot, restaurant owner, will have to say next week.
0 · Reply
Im_Trying
Im_Trying Mar. 18 at 2:03 PM
$NRXP worthless warrants
0 · Reply
jonny80s
jonny80s Mar. 18 at 12:03 PM
$NRXP let’s go!!! You need to pump it before you can dump it!
2 · Reply
BlazingStocks
BlazingStocks Mar. 17 at 7:15 PM
$NRXP - Published results have shown 87% clinical response to non-invasive Transcranial Magnetic Stimulation with neuroplastic medications. https://finance.yahoo.com/news/hope-therapeutics-nrx-subsidiary-nasdaq-110000927.html
1 · Reply
NetworkNewsWire
NetworkNewsWire Mar. 17 at 4:41 PM
BioMedNewsBreaks — $NRXP Receives FDA Feedback On Bioequivalence For Ketamine Product https://ibn.fm/fNDMM
1 · Reply
flybyme
flybyme Mar. 17 at 4:11 PM
$NRXP oh news and it falls as always , except for the surprise yesterday
3 · Reply
SmallCapGrowth
SmallCapGrowth Mar. 17 at 3:59 PM
#FrontPageStocks News: NRx Pharmaceuticals (Nasdaq: $NRXP) Announces FDA Bioequivalence Determination by Office of Generic Drugs for NRx’s Preservative-Free Ketamine Application https://youtube.com/shorts/IfM7vckk3SE https://finance.yahoo.com/news/nrx-pharmaceuticals-nasdaq-nrxp-announces-110000223.html @FRONTPAGESTOCKS #StockHighAlert #NRXP #NASDAQ #STOCKS
0 · Reply
jonny80s
jonny80s Mar. 17 at 3:12 PM
$NRXP is the q4 scheduled? Will they get it in before q1 closes?
1 · Reply
BlazingStocks
BlazingStocks Mar. 17 at 2:46 PM
$NRXP News March 09, 2026 HOPE Therapeutics, an NRx Subsidiary (Nasdaq:NRXP) Announces opening of Palm Beach, FL Clinic offering One Day treatment for Depression and PTSD https://finance.yahoo.com/news/hope-therapeutics-nrx-subsidiary-nasdaq-110000927.html
0 · Reply
IChiGOdoranZ
IChiGOdoranZ Mar. 17 at 2:39 PM
$NRXP News : NRx Pharmaceuticals (Nasdaq:NRXP) Announces FDA Bioequivalence Determination by Office of Generic Drugs for NRx’s Preservative-Free Ketamine Application https://ir.nrxpharma.com/news-releases/news-release-details/nrx-pharmaceuticals-nasdaqnrxp-announces-fda-bioequivalence
0 · Reply
Tonyboner
Tonyboner Mar. 17 at 2:35 PM
$NRXP No Rush to cover as they need money.
0 · Reply
UltimateTrader_22
UltimateTrader_22 Mar. 17 at 2:33 PM
$NRXP NRx Pharmaceuticals (Nasdaq:$NRXP) Announces FDA Bioequivalence Determination by Office of Generic Drugs for NRx’s Preservative-Free Ketamine Application Read More - https://ir.nrxpharma.com/news-releases/news-release-details/nrx-pharmaceuticals-nasdaqnrxp-announces-fda-bioequivalence #PharmaNews #mentalhealth #ketamine #PTSD #bipolar #psychiatry #healthcare #NRxPharma https://x.com/NRxPharma/status/2033864750963335460
0 · Reply